Resonance Health Ltd RHT
ASX · Australia · Health Services
AUD 0.0710+0.00 (+4.41%)
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · AUD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Resonance Health Ltd (ASX:RHT) delivers strong FY26 results with record revenue, positive EBITDA, and a robust pipeline for future growth.
NEW YORK, NY - January 15, 2026 (NEWMEDIAWIRE) - Synbio International Inc. (OTC: SYIN) ("Synbio" or the "Company"), a medical technology company focused on clinically validated AI diagnostics, today announced that it has executed a Master Services Ag...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.